Wilms Tumour 1 Peptide Vaccine as a Cure-Oriented Post-Chemotherapy Strategy for Patients With Acute Myeloid Leukaemia at High Risk of Relapse

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14768
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Early Parenteral Supplementation With Glutamine Dipeptide for Acute Myeloid Leukaemia Patients Receiving High Dose Chemotherapy

Journal of High Institute of Public Health
2015English

Isolated CNS Leukaemic Relapse in Acute Myeloid Leukaemia

BMJ Case Reports
Medicine
2019English

Venetoclax‐induced Tumour Lysis Syndrome in Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2019English

Prognosis of Patients With a Second Relapse of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients With Myeloid Malignancies at High Risk for Relapse

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

A New Peptide Vaccine OCV-501: In Vitro Pharmacology and Phase 1 Study in Patients With Acute Myeloid Leukemia

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2017English

Central Nervous System Involvement at First Relapse in Patients With Acute Myeloid Leukemia

Haematologica
Hematology
2011English

Is It Possible to Cure Childhood Acute Myeloid Leukaemia Without Significant Cardiotoxicity?

British Journal of Haematology
Hematology
2016English

High-Risk Adult Wilms’ Tumour in Pregnancy: A Case Report

Malawi Medical Journal
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy